載入中
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
最新資料
US$6.74
+US$0.18 · +2.74%
盤中時間採用ET。市場資料可能有所延遲。
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$35.00
上漲空間 419.29%價格歷史記錄不可用
最高：US$120平均的：US$35.00最低：US$2.00| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2023年12月8日 | 1:20 | — | — |
已生效 2023年12月8日
1:20
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
